Retrospective Cohort Study
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Apr 26, 2022; 10(12): 3677-3685
Published online Apr 26, 2022. doi: 10.12998/wjcc.v10.i12.3677
Predictors of unfavorable outcome at 90 days in basilar artery occlusion patients
Yu-Chen Chiu, Jia-Li Yang, Wei-Chun Wang, Hung-Yu Huang, Wei-Liang Chen, Pao-Sheng Yen, Ying-Lin Tseng, Hsiu-Hsueh Chen, Sheng-Ta Tsai
Yu-Chen Chiu, Department of Neurology, An Nan Hospital, China Medical University, Tainan 709204, Taiwan
Yu-Chen Chiu, Wei-Chun Wang, Hung-Yu Huang, Sheng-Ta Tsai, College of Medicine, China Medical University, Taichung 404332, Taiwan
Jia-Li Yang, Department of Anesthesiology, China Medical University Hospital, Taichung 404332, Taiwan
Wei-Chun Wang, Hung-Yu Huang, Sheng-Ta Tsai, Department of Neurology, China Medical University Hospital, Taichung 404332, Taiwan
Wei-Liang Chen, Ying-Lin Tseng, Department of Radiology, China Medical University Hospital, Taichung 404332, Taiwan
Pao-Sheng Yen, Department of Radiology, Kuang Tien General Hospital, Taichung 404332, Taiwan
Hsiu-Hsueh Chen, Stroke Center, China Medical University Hospital, Taichung 404332, Taiwan
Author contributions: Chiu YC contributed to the analysis and wrote the manuscript; Yang JL and Chen HH collected and analyzed the data; Wang WC revised the article; Huang HY designed the research; Chen WL, Yen PS, and Tseng YL provided substantial acquisition of data for the study; Tsai ST designed the research, wrote the manuscript, and supervised the report.
Supported by China Medical University Hospital, Taichung, Taiwan, No. DMR-111-103.
Institutional review board statement: This study secured ethical approval from the China Medical University Hospital, CMUH109-REC2-003.
Conflict-of-interest statement: The Authors declare that there is no conflict of interest.
Data sharing statement: The data that support the findings of this study are available on request from the corresponding author, STT.
STROBE statement: The authors have read the STROBE Statement—checklist of items, and the manuscript was prepared and revised according to the STROBE Statement—checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Sheng-Ta Tsai, MD, PhD, Attending Doctor, Doctor, Department of Neurology, China Medical University Hospital, No. 2 Yude Road, North District, Taichung 404332, Taiwan. tshengdar@gmail.com
Received: August 10, 2021
Peer-review started: August 10, 2021
First decision: October 20, 2021
Revised: November 1, 2021
Accepted: March 14, 2022
Article in press: March 14, 2022
Published online: April 26, 2022
Core Tip

Core Tip: In the emergency department, basilar artery occlusion (BAO) stroke is always severe, devastating, and difficult to diagnose. And it is more difficult to determine the further treatment, thrombectomy or not? We perform a retrospective study to investigate the outcome predictors of BAO. Our study showed that initial National Institutes of Health Stroke Scale (NIHSS) was the strongest predictor to the 90 d functional outcome. And we found a best cut-off value of NIHSS 30. That is, the score higher than 30 always relate to poor outcome, even received thrombectomy. We suggest that BAO patients with NIHSS higher than 30 may not benefit from thrombectomy treatment.